186 related articles for article (PubMed ID: 23973321)
1. Safety of 13-valent pneumococcal conjugate vaccine in infants and children: meta-analysis of 13 clinical trials in 9 countries.
Thompson A; Gurtman A; Patterson S; Juergens C; Laudat F; Emini EA; Gruber WC; Scott DA
Vaccine; 2013 Oct; 31(45):5289-95. PubMed ID: 23973321
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of 13-valent pneumococcal conjugate vaccine and concomitant meningococcal group C conjugate vaccine in healthy infants and toddlers in Spain.
Diez-Domingo J; Gurtman A; Bernaola E; Gimenez-Sanchez F; Martinon-Torres F; Pineda-Solas V; Delgado A; Infante-Marquez P; Liang JZ; Giardina PC; Gruber WC; Emini EA; Scott DA
Vaccine; 2013 Nov; 31(46):5486-94. PubMed ID: 24004465
[TBL] [Abstract][Full Text] [Related]
3. Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine in healthy infants and toddlers given with routine pediatric vaccinations in Canada.
Vanderkooi OG; Scheifele DW; Girgenti D; Halperin SA; Patterson SD; Gruber WC; Emini EA; Scott DA; Kellner JD;
Pediatr Infect Dis J; 2012 Jan; 31(1):72-7. PubMed ID: 21960186
[TBL] [Abstract][Full Text] [Related]
4. Safety, tolerability and immunogenicity of 15-valent pneumococcal conjugate vaccine in toddlers previously vaccinated with 7-valent pneumococcal conjugate vaccine.
Sobanjo-ter Meulen A; Vesikari T; Malacaman EA; Shapiro SA; Dallas MJ; Hoover PA; McFetridge R; Stek JE; Marchese RD; Hartzel J; Watson WJ; Musey LK
Pediatr Infect Dis J; 2015 Feb; 34(2):186-94. PubMed ID: 25741971
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in healthy infants in Japan.
Togashi T; Yamaji M; Thompson A; Giardina PC; Aizawa M; Patterson S; Gruber WC; Scott DA;
Pediatr Infect Dis J; 2013 Sep; 32(9):984-9. PubMed ID: 23538524
[TBL] [Abstract][Full Text] [Related]
6. Long-term immune responses to pneumococcal conjugate vaccines in children previously vaccinated with 7-valent pneumococcal conjugate vaccine.
Klein NP; Ensor K; Jouve S; Northington R; Moscariello M; McGovern PC
Pediatr Infect Dis J; 2013 Sep; 32(9):990-7. PubMed ID: 24008739
[TBL] [Abstract][Full Text] [Related]
7. 13-Valent pneumococcal conjugate vaccine (PCV13) in children partially immunized with 7-valent pneumococcal conjugate vaccine (PCV7): a phase 3, open-label trial.
Silfverdal SA; Flodmark CE; Rombo L; Tansey SP; Sidhu M; Trammel J; Emini EA; Gruber WC; Scott DA; Gurtman A;
Vaccine; 2013 Feb; 31(9):1284-92. PubMed ID: 23306363
[TBL] [Abstract][Full Text] [Related]
8. 13-valent pneumococcal conjugate vaccine given with meningococcal C-tetanus toxoid conjugate and other routine pediatric vaccinations: immunogenicity and safety.
Martinón-Torres F; Gimenez-Sanchez F; Gurtman A; Bernaola E; Diez-Domingo J; Carmona A; Sidhu M; Sarkozy DA; Gruber WC; Emini EA; Scott DA;
Pediatr Infect Dis J; 2012 Apr; 31(4):392-9. PubMed ID: 22301472
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in infants and toddlers.
Yeh SH; Gurtman A; Hurley DC; Block SL; Schwartz RH; Patterson S; Jansen KU; Love J; Gruber WC; Emini EA; Scott DA;
Pediatrics; 2010 Sep; 126(3):e493-505. PubMed ID: 20732948
[TBL] [Abstract][Full Text] [Related]
10. A phase 3, randomized, double-blind trial comparing the safety and immunogenicity of the 7-valent and 13-valent pneumococcal conjugate vaccines, given with routine pediatric vaccinations, in healthy infants in Brazil.
Weckx LY; Thompson A; Berezin EN; de Faria SM; da Cunha CA; Pride M; Patterson S; Gruber WC; Emini EA; Scott DA;
Vaccine; 2012 Dec; 30(52):7566-72. PubMed ID: 23099331
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in healthy infants and toddlers given with routine vaccines in India.
Amdekar YK; Lalwani SK; Bavdekar A; Balasubramanian S; Chhatwal J; Bhat SR; Verghese VP; Tansey SP; Gadgil D; Jiang Q; Pride M; Emini EA; Gruber WC; Scott DA
Pediatr Infect Dis J; 2013 May; 32(5):509-16. PubMed ID: 23190777
[TBL] [Abstract][Full Text] [Related]
12. Safety and immunogenicity of 13-valent pneumococcal conjugate vaccine in infants: a meta-analysis.
Ruiz-Aragón J; Márquez Peláez S; Molina-Linde JM; Grande-Tejada AM
Vaccine; 2013 Nov; 31(46):5349-58. PubMed ID: 24055349
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in children previously immunized with 7-valent pneumococcal conjugate vaccine.
Frenck R; Thompson A; Yeh SH; London A; Sidhu MS; Patterson S; Gruber WC; Emini EA; Scott DA; Gurtman A;
Pediatr Infect Dis J; 2011 Dec; 30(12):1086-91. PubMed ID: 21983216
[TBL] [Abstract][Full Text] [Related]
14. Pneumococcal conjugate vaccine-elicited antibody persistence and immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in children previously vaccinated with 4 doses of either 7-valent or 13-valent pneumococcal conjugate vaccine.
Quinet B; Laudat F; Gurtman A; Patterson S; Sidhu M; Gruber WC; Scott DA
Pediatr Infect Dis J; 2014 Oct; 33(10):1065-76. PubMed ID: 25093973
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine Compared With 7-valent Pneumococcal Conjugate Vaccine Among Healthy Infants in China.
Zhu F; Hu Y; Li J; Ye Q; Young MM; Zhou X; Chen Z; Yan B; Liang JZ; Gruber WC; Giardina PC; Scott DA
Pediatr Infect Dis J; 2016 Sep; 35(9):999-1010. PubMed ID: 27254028
[TBL] [Abstract][Full Text] [Related]
16. The 13-valent pneumococcal conjugate vaccine for invasive pneumococcal disease in Alaska native children: results of a clinical trial.
Singleton R; Wenger J; Klejka JA; Bulkow LR; Thompson A; Sarkozy D; Emini EA; Gruber WC; Scott DA
Pediatr Infect Dis J; 2013 Mar; 32(3):257-63. PubMed ID: 23001026
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine (PCV13) when given as a toddler dose to children immunized with PCV7 as infants.
Grimprel E; Laudat F; Patterson S; Baker SA; Sidhu MS; Gruber WC; Emini EA; Scott DA
Vaccine; 2011 Dec; 29(52):9675-83. PubMed ID: 22008822
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine administered to older infants and children naïve to pneumococcal vaccination.
Wysocki J; Brzostek J; Szymański H; Tetiurka B; Toporowska-Kowalska E; Wasowska-Królikowska K; Sarkozy DA; Giardina PC; Gruber WC; Emini EA; Scott DA
Vaccine; 2015 Mar; 33(14):1719-25. PubMed ID: 25698485
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity, reactogenicity and safety of a 7-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a DTPa-HBV-IPV/Hib combination vaccine in healthy infants.
Knuf M; Habermehl P; Cimino C; Petersen G; Schmitt HJ
Vaccine; 2006 May; 24(22):4727-36. PubMed ID: 16616973
[TBL] [Abstract][Full Text] [Related]
20. Surveillance of adverse events following the introduction of 13-valent pneumococcal conjugate vaccine in infants, and comparison with adverse events following 7-valent pneumococcal conjugate vaccine, in Victoria, Australia.
Littlejohn ES; Clothier HJ; Perrett KP; Danchin M
Hum Vaccin Immunother; 2015; 11(7):1828-35. PubMed ID: 26075435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
